Daiichi Sankyo to donate $1M for COVID-19 relief fund

Daiichi Sankyo Company, Limited has announced that, through the Japan Center for International Exchange, it will make a ...

April 17, 2020 | Friday | News
Fujifilm accelerates favipiravir production for COVID-19 treatment

Fujifilm is ramping up production of its antiviral treatment drug favipiravir, one of many approved drugs being tested...

April 16, 2020 | Thursday | News
Daiichi Sankyo commences gene therapy research to restore vision

Japan based Daiichi Sankyo Company, Limited, Mitsubishi UFJ Capital Co., Ltd. and Nagoya Institute of Technology ha...

April 14, 2020 | Tuesday | News
Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy

Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...

April 10, 2020 | Friday | News
Chugai starts Ph III trial of Actemra for COVID-19 pneumonia

Japan based Chugai Pharmaceutical Co., Ltd. has announced that it is working to start a Phase III clinical trial in Japa...

April 10, 2020 | Friday | News
Jolly Good, NCCBTR collaborate for VR Therapeutics

Japanese startup Jolly Good Inc. and the National Center for Cognitive Behavior Therapy and Research (NCCBTR) announced ...

April 6, 2020 | Monday | News
SanBio, Ocumension enter into biz alliance for treating eye diseases

Japan based SanBio and Hong Kong based Ocumension have entered into a business alliance for the research, development an...

April 7, 2020 | Tuesday | News
Genesis Healthcare unveils new detection test for COVID-19

Genesis Healthcare Co., Japan's leading genetic testing and research company, today announced the launch of a real-time ...

April 3, 2020 | Friday | News
Japan Coronavirus COVID-19 (2019-nCoV) Pandemic Dashboard : Daily Confirmed Cases

Daily New Confirmed Cases : Japan   ...

April 3, 2020 | Friday | News
Japan’s MEXT awarded the A-PRAS certificate to Impact Science

Japan’s Ministry of Education, Culture, Sports, Science and Technology (MEXT) awarded Impact Science with the Accr...

April 2, 2020 | Thursday | News
Daiichi Sankyo, Ultragenyx partner for gene therapy manufacturing technology

Japan based Daiichi Sankyo Company, Limited has announced that it has entered into a strategic partnership with US based...

April 1, 2020 | Wednesday | News
GHIT Fund announces new investment of 3.29 B Yen

Japan based Global Health Innovative Technology (GHIT) Fund has announced a total of 3.29 billion yen (US$30 m...

April 1, 2020 | Wednesday | News
Hitachi to establish Lumada Data Science lab

Japan based Hitachi, Ltd. on 30 March 2020 announced that on April 1, it will establish the "Lumada(1) Data Science Lab....

March 31, 2020 | Tuesday | News
Daiichi Sankyo ends influenza vaccine sales deal with Kitasato

Japan based Daiichi Sankyo Company, Limited and Kitasato Pharmaceutical Industry Co., Ltd. have announced the terminatio...

March 30, 2020 | Monday | News
CG Oncology inks agreement with Kissei Pharma for $40M

US based CG Oncology, Inc. has announced an exclusive license, development and commercialization agreement with Japanese...

March 27, 2020 | Friday | News
Daiichi Sankyo receives approval for new breast cancer drug

Japan based Daiichi Sankyo Company, Limited has announced the approval of ENHERTU® (trastuzumab deruxtecan), a HER2 ...

March 26, 2020 | Thursday | News
CytomX, Astellas to find cure for cancer

US based CytomX Therapeutics and Japan based Astellas Pharma have entered into a strategic collaboration agreement focus...

March 25, 2020 | Wednesday | News
Diagnostic biomarker for acute adult T-cell cancers discovered

A study jointly conducted by Dean and Professor Takuya Fukushima, M.D., Ph.D., Graduate School of Health Sciences, Unive...

March 23, 2020 | Monday | News